Mobile

A Randomized Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Subjects With Type 2 Diabetes Mellitus With Inadequate Glucose Control and on Metformin Monotherapy

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-024256-28

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

After 18 weeks of treatment: -To assess the effect of canagliflozin 150 mg administered twice daily on HbA1c relative to placebo - To assess the safety and tolerability of canagliflozin

Critère d'inclusion

  • Subjects with T2DM with inadequate glycemic control on a maximally effective dose of metformin in monotherapy

Liens